Recombinant Human Interleukin-6 (IL6) (Active) (GMP) - CD BioSciences

service-banner

Recombinant Human Interleukin-6 (IL6) (Active) (GMP)

Recombinant Human Interleukin-6 (IL6) (Active) (GMP)

SPP-02981

Size Price
1 mg Online Inquiry
100 μg Online Inquiry
5 μg Online Inquiry
Target Information
Species Homo sapiens
Target Name IL-6
UniProt No. P05231
Subcellular Location Secreted
Gene Abbr. IL6
Full Name interleukin 6
Alias BSF-2, BSF2, CDF, HGF, HSF
Introduction Acute phase response is induced by interleukin-6 (IL-6) produced by T cells, macrophages, fibroblasts, endothelial and other cells. IL-6 induces proliferation or differentiation in many cell types including B cells, thymocytes and T cells. IL-6, in concert with TGF-β, is important for developing Th17 responses. IL-6 binds to IL-6Rα and through this association induces gp130 homodimerization. gp130 homodimerization triggers the Jak/Stat cascade and the SHP-2/Erk MAP kinase cascade. IL-6 also forms a complex with an IL-6Rα splice variant that is nonmembrane-associated. The IL-6/soluble IL-6Rα complex can then activate the gp130 signaling pathway in cells that express gp130 but not IL-6Rα. Research studies have shown that IL-6, through increasing expression of proangiogenic VEGF, may also contribute to metastatic breast cancer.
Product Details
Product Type Recombinant Protein
Product Form Lyophilized powder
Buffer before Lyophilization Lyophilized from a 0.2 µm filtered concentrated solution in 20 mM Tris-HCl, pH 8.0, 150 mM NaCl.
Storage & Handling
Storage Temp. Store at -20 °C upon receipt unless otherwise instructed.
Handling Aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.

For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.